(MENAFNEditorial)
AlerSense Incorporated has created the world’s first smart airborne allergy and asthma early warning system alerting consumers as particles and toxins build. AlerSense™ is an in-home unit when combined with the mobile app delivers accurate environmental readings giving asthma and allergy sufferers precious time to remove themselves from or alter the environment. AlerSense™ delivers precise in-home measurements of airborne contamination and toxins such as pollen mold dust dust mite waste VOC’s and animal dander helping consumers monitor the levels of airborne contamination in the environment that could have a role in causing an allergy or asthma attack. AlerSense™ also tracks humidity and temperature thus creating a holistic air quality assessment.
AlerSense™ was founded by a team of passionate people who were determined to change the way we look allergies and asthma caused by airborne contaminants. “For the longest time we have accepted the fact that allergies and asthma attacks ‘just happen’. We wanted to work on a project that would help people throughout the world understand when contaminants are building in the home so that they can make the appropriate adjustments” said Skip Sanzeri founder and CEO of AlerSense. “We’ve combined some of the world’s most advanced sensors with a smart mobile app and extensive software algorithms that will allow users to record allergy and asthma symptoms at the time when they first noticed the symptoms. Our goal is to give consumers enough time so they have a change the environment. And the system gets smarter as it learns each family member’s sensitivities based on user input. Airborne contaminants are usually invisible to the naked eye and therefore attack unannounced. Well we’re here to make the announcement.”
AlerSense™ units will be available in the spring of 2016. Interested customers may preorder AlerSense™ via the AlerSense™ website at .
Global Problems
The global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. According to the U. S. Center for Disease Control (CDC) it is estimated that 1 in 12 Americans has asthma. Additionally the CDC estimates that 17.6 million Americans were diagnosed with hay fever in the past 12 months.
About AlerSense™
AlerSense™ stands for ‘Aler’ (Alert Allergy) and ‘Sense’ (detect and report). AlerSense™ is committed to providing high quality consumer airborne contaminant sensing solutions. Based in Silicon Valley and Dublin Ireland AlerSense™ will help change the world by playing a role in reducing allergy and asthma issues.
For further information please visit or send an email to .
Company Contact:
AlerSense Inc.
Skip Sanzeri
Founder CEO
Tel 1 650 504 0465
skip@alersense.com
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.